# A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

> **NCT05110976** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 170 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD8630
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05110976
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-16
- **Primary completion:** 2023-08-02
- **Final completion:** 2023-08-02
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05110976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05110976, "A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05110976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*